Bajaj Healthcare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
420.50
-3.45 (-0.81%)
BSENSE

Dec 05

BSE+NSE Vol: 38.96 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.84% vs 14.89% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 38.19% vs 132.13% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 4.93% vs 20.49% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is -33.95% vs -4.06% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has fallen from Sep 2024

Compare Half Yearly Results Of Bajaj Healthcare With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
296.75
194.92
101.83
52.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
296.75
194.92
101.83
52.24%
Raw Material Cost
144.69
93.46
51.23
54.81%
Purchase of Finished goods
0.00
3.68
-3.68
-100.00%
(Increase) / Decrease In Stocks
9.50
-2.35
11.85
504.26%
Employee Cost
30.86
32.32
-1.46
-4.52%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
60.24
37.19
23.05
61.98%
Total Expenditure (Excl Depreciation)
245.29
164.30
80.99
49.29%
Operating Profit (PBDIT) excl Other Income
51.46
30.62
20.84
68.06%
Other Income
2.53
6.43
-3.90
-60.65%
Operating Profit (PBDIT)
53.99
37.05
16.94
45.72%
Interest
10.78
4.67
6.11
130.84%
Exceptional Items
-1.68
-116.35
114.67
98.56%
Gross Profit (PBDT)
43.21
-83.97
127.18
151.46%
Depreciation
12.72
7.26
5.46
75.21%
Profit Before Tax
30.49
-91.23
121.72
133.42%
Tax
5.86
-3.84
9.70
252.60%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
24.62
-87.38
112.00
128.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
-1.68
0.00
-1.68
Net Profit
22.94
-87.38
110.32
126.25%
Equity Capital
15.79
38.21
-22.42
-58.68%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.26
-2.29
9.55
417.03%
Diluted Earnings per share
7.11
-2.29
9.40
410.48%
Operating Profit Margin (Excl OI)
17.34%
15.71%
0.00
1.63%
Gross Profit Margin
14.56%
-43.08%
0.00
57.64%
PAT Margin
8.30%
-44.83%
0.00
53.13%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 296.75 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.84% vs 14.89% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 22.94 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 38.19% vs 132.13% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.46 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 4.93% vs 20.49% in Sep 2024

Half Yearly - Interest
Interest 10.78 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -33.95% vs -4.06% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.34%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has fallen from Sep 2024